Filter
1658
Text search:
ART
drugs
Featured
173
566
Language
Document type
1081
216
160
75
43
40
26
5
5
3
3
1
Countries
130
64
62
61
49
48
44
41
39
35
33
32
30
30
28
25
23
22
22
22
18
18
17
17
16
16
16
13
13
12
11
11
10
8
8
6
6
5
5
5
5
5
5
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
882
141
64
50
46
42
15
1
Toolboxes
206
187
109
46
44
31
26
24
23
16
14
13
12
12
10
9
8
7
6
5
3
3
2
2
1
The purpose of the PAS III is to guide Pakistan’s overall national response for HIV and AIDS through 2020, through focused interventions with set targets, costs, roles and responsibilities. The successful implementation of PAS III involves multiple stakeholders to achieve priority outcomes outline
...
Accessed online August 2018
BMC Public Health (2018) 18:668 https://doi.org/10.1186/s12889-018-5594-3
This article identifies the three core defining characteristics of healing environments for children and young people who have been exposed to chronic adversity and trauma. A large body of evidence highlights the pervasive and devastating developmental impacts of such exposure but there is also emer
...
Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
Q12: Should the treatment be similar in individuals with intellectual disability and epilepsy compared to people with epilepsy only?
Q1: Are brief psychosocial interventions for people using cannabis or psychostimulants effective in reducing drug use, dependence and harm from drug use?
SCOPING QUESTION:Which psychosocial interventions are effective in the treatment of psychostimulant dependence for adults and young people?
Externalizing disorders
Chapter 1.1
Trastornos externalizantes
Capítulo D.1.1
Edición: Matías Irarrázaval & Andres Martin
Traductores: Fernanda Prieto-Tagle & Carlos Gómez
SRHR, HIV AND AIDS Governance Manual
Framework of Indictors and Targets
Technical Brief
HIV patient monitoring and case surveillance
WHO/HIV/2017.12
Accessed on 28.02.2020
